HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

CY 208-243

structure given in first source
Also Known As:
4,6,6a,7,8,12b-hexahydro-7-methylindolo(4,3-ab)-phenanthridine; CY-208-243; indolophenanthridine; Indolo(4,3-ab)phenanthridine, 4,6,6a,7,8,12b-hexahydro-7-methyl-, trans-(-)-
Networked: 13 relevant articles (2 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Betz, Adrienne: 1 article (01/2005)
2. Carlson, Brian B: 1 article (01/2005)
3. Correa, Merce: 1 article (01/2005)
4. Lentini, Elizabeth: 1 article (01/2005)
5. Rios, Clifford: 1 article (01/2005)
6. Salamone, John D: 1 article (01/2005)
7. Wisniecki, Ania: 1 article (01/2005)

Related Diseases

1. Parkinson Disease (Parkinson's Disease)
2. Tremor (Tremors)
3. Dyskinesias (Dyskinesia)
4. Parkinsonian Disorders (Parkinsonism)
5. Respiratory Insufficiency (Respiratory Failure)

Related Drugs and Biologics

1. Dopamine Agonists (Dopamine Agonist)
2. 1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)
3. Levodopa (L Dopa)
4. Dopamine (Intropin)
5. 4,4a,5,6,7,8,8a,9- octahydro- 5- propyl- 1H- pyrzolo(3,4- g)quinoline
6. Dopamine D2 Receptor Antagonists
7. Cholinergic Agents (Cholinergics)
8. Dopamine D1 Receptors (Dopamine D1 Receptor)
9. 2,3,4,5- Tetrahydro- 7,8- dihydroxy- 1- phenyl- 1H- 3- benzazepine (SKF 38393)
10. Sulpiride (neogama)

Related Therapies and Procedures

1. Therapeutics
2. Denervation